Cross-talk between Notch and EGFR signaling in human breast cancer cells

Cancer Investigation

Volumn 27, Issue 5, 2009, Pages 533-540

  Dai, Jianjian ^a   Ma, Daoxin ^a   Zang, Shaolei ^a   Guo, Dongmei ^a   Qu, Xun ^a   Ye, Jingjing ^a   Ji, Chunyan ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Apoptosis; EGFR inhibitor; Human breast cancer; Notch1; Proliferation

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; NOTCH1 RECEPTOR; EGFR PROTEIN, HUMAN; MESSENGER RNA; NOTCH1 PROTEIN, HUMAN; PROTEIN KINASE INHIBITOR; QUINAZOLINE DERIVATIVE;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; BREAST TUMOR; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GENETICS; KIDNEY; METABOLISM; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; HUMANS; KIDNEY; PROTEIN KINASE INHIBITORS; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, NOTCH1; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 67449096301     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900802563036     Document Type: Article

References (39)

1. Reedijk, M.; Pinnaduwage, D.; Dickson, B.C.; Mulligan, A.M.; Zhang, H.; Bull, S.B.; O'Malley, F.P.; Egan, S.E.; Andrulis, I.L. JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer. Breast Cancer Res Treat 2007, DOI 10.1007/s10549-007-9805-3.
2. Reedijk, M.; Odorcic, S.; Chang, L.; Zhang, H.; Miller, N.; McCready, D.R.; Lockwood, G.; Egan, S.E. High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res 2005, 65(18), 8530-8537.
3. Li, J.L.; Harris, A.L. Notch signaling from tumor cells: a new mechanism of angiogenesis. Cancer Cell 2005, 8(1), 1-3.
4. Clark, P.A.; Treisman, D.M.; Ebben, J.; Kuom J.S. Developmental signaling pathways in brain tumor-derived stem-like cells. Dev Dyn 2007, 236(12), 3297-3308.
5. Weng, A.P.; Aster, J.C. Multiple niches for Notch in cancer: context is everything. Curr Opin Genet Dev 2004, 14(1), 48-54.
6. Bhanot, U.K.; KÖhntop, R.; Hasel, C.; MÖller, P. Evidence of Notch pathway activation in the ectatic ducts of chronic pancreatitis. J Pathol 2008, 214(3), 312-319.
7. Ehebauer, M.; Hayward, P.; Arias, A.M. Notch, a universal arbiter of cell fate decisions. Science 2006, 314(5804), 1414-1415.
8. Shi, W.; Harris, A.L. Notch signaling in breast cancer and tumor angiogenesis: cross-talk and therapeutic potentials. J Mammary Gland Biol Neoplasia 2006, 11(1), 41-52.
9. Hurlbut, G.D.; Kankel, M.W.; Lake, R.J.; Artavanis-Tsakonas, S. Crossing paths with Notch in the hyper-network. Curr Opin Cell Biol 2007, 19(2), 166-175.
10. Leong, K.G.; Karsan, A. Recent insights into the role of Notch signaling in tumorigenesis. Blood 2006, 107(6), 2223-2233. (Pubitemid 43345539)
11. Ramdass, B.; Maliekal, T.T.; Lakshmi, S.; Rehman, M.; Rema, P.; Nair, P.; Mukherjee, G.; Reddy, B.K.; Krishna, S.; Radhakrishna Pillai, M. Coexpression of Notch1 and NF-κB signaling pathway components in human cervical cancer progression. Gynecol Oncol 2007, 104(2), 352-361.
12. Katoh, M.; Katoh, M. Notch signaling in gastrointestinal tract. Int J Oncol 2007, 30(1), 247-251.
13. Takaori, K. Current understanding of precursors to pancreatic cancer. J Hepatobiliary Pancreat Surg 2007, 14(3), 217-223. (Pubitemid 46863909)
14. Kanamori, M.; Kawaguchi, T.; Nigro, J.M.; Feuerstein, B.G.; Berger, M.S.;Miele, L.; Pieper, R.O. Contribution of Notch signaling activation to human glioblastoma multiforme. J Neurosurg 2007, 106(3), 417-427.
15. Curry, C.L.; Reed, L.L.; Broude, E.; Golde, T.E.; Miele, L.; Foreman, K.E. Notch inhibition in Kaposi's sarcoma tumor cells leads to mitotic catastrophe through nuclear factor-κB signaling. Mol Cancer Ther 2007, 6(7), 1983-1992.
16. Pece, S.; Serresi, M.; Santolini, E.; Capra, M.; Hulleman, E.; Galimberti, V.; Zurrida, S.; Maisonneuve, P.; Viale, G.; Di Fiore, P.P. Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J Cell Biol 2004, 167(2), 215-221.
17. Lu, Z.; Jiang, G.; Blume-Jensen, P.; Hunter, T. Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase. Mol Cell Biol 2001, 21(12), 4016-4031. (Pubitemid 32476463)
18. Friedmann, B.J.; Caplin, M.; Savic, B.; Shah, T.; Lord, C.J.; Ashworth, A.; Hartley, J.A.; Hochhauser, D. Interaction of the epidermal growth factor receptor and the DNA-dependent protein kinase pathway following gefitinib treatment. Mol Cancer Ther 2006, 5(2), 209-218.
19. Dutta, P.R.; Maity, A. Cellular responses to EGFR inhibitors and their relevance to cancer therapy. Cancer Lett 2007, 254(2), 165-177. (Pubitemid 47161103)
20. Qi, R.; An, H.; Yu, Y.; Zhang, M.; Liu, S.; Xu, H.; Guo, Z.; Cheng, T.; Cao, X. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis. Cancer Res 2003, 63(23), 8323-8329. (Pubitemid 37549485)
21. Hu, Y.; Nguyen, T.T.; Bui, K.C.; Demello, D.E.; Smith, J.B. A novel inflammation-induced ubiquitin E3 ligase in alveolar type II cells. Biochem Biophys Res Commun 2005, 333(1), 253-263.
22. Freeman, B.B.; Daw, N.C.; Geyer, J.R.; Furman, W.L.; Stewart, C.F. Evaluation of gefitinib for treatment of refractory solid tumors and central nervous system malignancies in pediatric patients. Cancer Invest 2006, 24(3), 310-317.
23. Farnie, G.; Clarke, R.B. Mammary stem cells and breast cancer - role of Notch signaling. Stem Cell Rev 2007, 3(2), 169-175. (Pubitemid 350129719)
24. Bailey, J.M.; Singh, P.K.; Hollingsworth, M.A. Cancer metastasis facilitated by developmental pathways: sonic hedgehog, Notch, and bone morphogenic proteins. J Cell Biochem 2007, 102(4), 829-839.
25. Imatani, A.; Callahan, R. Identification of a novel Notch4/int-3 RNA species encoding an activated gene product in certain human tumor cell lines. Oncogene 2000, 19(2), 223-231. (Pubitemid 30077218)
26. Stylianou, S.; Clarke, R.B.; Brennan, K. Aberrant activation of Notch signaling in human breast cancer. Cancer Res 2006, 66(3), 1517-1525. (Pubitemid 43259933)
27. Siziopikou, K.; Jang, M.S.; Miao, H.; Miele, L. Notch signaling in ductal carcinoma in situ of the breast [abstract]. Proc Am Assoc Cancer Res 2002, 43, 4.
28. Weijzen, S.; Rizzo, P.; Braid, M.; Vaishnav, R.; Jonkheer, S.M.; Zlobin, A.; Osborne, B.A.; Gottipati, S.; Aster, J.C.; Hahn, W.C.; Rudolf, M.; Siziopikou, K.; Kast, W.M.; Miele, L. Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med 2002, 8(9), 979-986. (Pubitemid 35033702)
29. Reedijk, M.; Odorcic, S.; Chang, L.; Zhang, H.; Miller, N.; McCready, D.R.; Lockwood, G.; Egan, S.E. High-level coexpression of Jag1 and Notch1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res 2005, 65(18), 8530-8537.
30. Zang, S.; Ji, Ch.; Qu, X.; Dong, X.; Ma, D.; Ye, J.; Ma, R.; Dai, J.; Guo, D. A study on Notch signaling in human breast cancer. Neoplasma 2007, 54(4), 304-310.
31. Dickson, B.C.; Mulligan, A.M.; Zhang, H.; Lockwood, G.; O'Malley, F.P.; Egan, S.E.; Reedijk, M. High-level JAG1 mRNA and protein predict poor outcome in breast cancer. Mod Pathol 2007, 20(6), 685-693. (Pubitemid 46788875)
32. Rizzo, P.; Miao, H.; D'Souza, G.; Osipo, C.; Yun, J.; Zhao, H.; Mascarenhas, J.; Wyatt, D.; Antico, G.; Hao, L.; Yao, K.; Rajan, P.; Hicks, C.; Siziopikou, K.; Selvaggi, S.; Bashir, A.; Bhandari, D.; Marchese, A.; Lendahl, U.; Qin, J.Z.; Tonetti, D.A.; Albain, K.; Nickoloff, B.J.; Miele, L. Cross-talk between Notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. Cancer Res 2008, 68(13), 5226-5235.
33. Lee, C.W.; Raskett, C.M.; Prudovsky, I.; Altieri, D.C. Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis. Cancer Res 2008, 68(13), 5273-5281.
34. Schiff, B.A.; McMurphy, A.B.; Jasser, S.A.; Younes, M.N.; Doan, D.; Yigitbasi, O.G.; Kim, S.; Zhou, G.; Mandal, M.; Bekele, B.N.; Holsinger, F.C.; Sherman, S.I.; Yeung, S.C.; El-Naggar, A.K.; Myers, J.N. Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer. Clin Cancer Res 2004, 10(24), 8594-8602. (Pubitemid 40053427)
35. Doroquez, D.B.; Rebay, I. Signal integration during development: mechanisms of EGFR and Notch pathway function and cross-talk. Crit Rev Biochem Mol Biol 2006, 41(6), 339-385. (Pubitemid 44722140)
36. Purow, B.W.; Sundaresan, T.K.; Burdick, M.J.; Kefas, B.A.; Comeau, L.D.; Hawkinson, M.P.; Su, Q.; Kotliarov, Y.; Lee, J.; Zhang, W.; Fine, H.A. Notch-1 regulates transcription of the epidermal growth factor receptor through p53. Carcinogenesis 2008, 29(5), 918-925. (Pubitemid 351982234)
37. Kolev, V.; Mandinova, A.; Guinea-Viniegra, J.; Hu, B.; Lefort, K.; Lambertini, C.; Neel, V.; Dummer, R.; Wagner, E.F.; Dotto, G.P. EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer. Nat Cell Biol 2008, 278(3), 1824-1830.
38. Farnie, G.; Clarke, R.B.; Spence, K.; Pinnock, N.; Brennan, K.; Anderson, N.G.; Bundred, N.J. Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways. J Natl Cancer Inst 2007, 99(8), 616-627.
39. Wang, Z.; Zhang, Y.; Li, Y.; Banerjee, S.; Liao, J.; Sarkar, F.H. Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells. Mol Cancer Ther 2006, 5(3), 483-493.